Tay Darwin, Poh Chueh Loo, Kitney Richard I
Department of Bioengineering, Imperial College London, UK; Division of Bioengineering, Nanyang Technological University, Singapore.
Division of Bioengineering, Nanyang Technological University, Singapore.
J Biomed Inform. 2015 Apr;54:305-14. doi: 10.1016/j.jbi.2014.12.014. Epub 2015 Jan 6.
Clinical risk prediction - the estimation of the likelihood an individual is at risk of a disease - is a coveted and exigent clinical task, and a cornerstone to the recommendation of life saving management strategies. This is especially important for individuals at risk of cardiovascular disease (CVD) given the fact that it is the leading causes of death in many developed counties. To this end, we introduce a novel learning algorithm - a key factor that influences the performance of machine learning-based prediction models - and utilities it to develop CVD risk prediction tool. This novel neural-inspired algorithm, called the Artificial Neural Cell System for classification (ANCSc), is inspired by mechanisms that develop the brain and empowering it with capabilities such as information processing/storage and recall, decision making and initiating actions on external environment. Specifically, we exploit on 3 natural neural mechanisms responsible for developing and enriching the brain - namely neurogenesis, neuroplasticity via nurturing and apoptosis - when implementing ANCSc algorithm. Benchmark testing was conducted using the Honolulu Heart Program (HHP) dataset and results are juxtaposed with 2 other algorithms - i.e. Support Vector Machine (SVM) and Evolutionary Data-Conscious Artificial Immune Recognition System (EDC-AIRS). Empirical experiments indicate that ANCSc algorithm (statistically) outperforms both SVM and EDC-AIRS algorithms. Key clinical markers identified by ANCSc algorithm include risk factors related to diet/lifestyle, pulmonary function, personal/family/medical history, blood data, blood pressure, and electrocardiography. These clinical markers, in general, are also found to be clinically significant - providing a promising avenue for identifying potential cardiovascular risk factors to be evaluated in clinical trials.
临床风险预测——即估计个体患某种疾病的可能性——是一项令人垂涎且紧迫的临床任务,也是推荐挽救生命的管理策略的基石。鉴于心血管疾病(CVD)是许多发达国家的主要死因,这对于有心血管疾病风险的个体尤为重要。为此,我们引入了一种新颖的学习算法——这是影响基于机器学习的预测模型性能的关键因素——并利用它开发心血管疾病风险预测工具。这种新颖的受神经启发的算法,称为用于分类的人工神经细胞系统(ANCSc),其灵感来自于大脑发育的机制,并赋予其诸如信息处理/存储和回忆、决策以及对外部环境采取行动等能力。具体而言,在实施ANCSc算法时,我们利用了负责大脑发育和丰富的三种自然神经机制,即神经发生、通过滋养实现的神经可塑性和细胞凋亡。使用檀香山心脏项目(HHP)数据集进行了基准测试,并将结果与其他两种算法——即支持向量机(SVM)和进化数据感知人工免疫识别系统(EDC-AIRS)进行了对比。实证实验表明,ANCSc算法在统计上优于SVM和EDC-AIRS算法。ANCSc算法识别出的关键临床标志物包括与饮食/生活方式、肺功能、个人/家族/病史、血液数据、血压和心电图相关的风险因素。一般来说,这些临床标志物在临床上也具有重要意义——为识别潜在的心血管风险因素提供了一条有前景的途径,以便在临床试验中进行评估。